Science Explorer Back to mapMap
Discussion
Company · Watertown · United States

Enanta Pharmaceuticals (United States)

enanta.comROR OpenAlex
Research works
55
▲ 15% vs 2018-21
Citations
927
16.9 per fractional work
Top-10% rate
11.8%
all institutions 10.0%
Open access
45%
world 40%
International
18%
world 18%
Enanta Pharmaceuticals (United States)

Not ranked overall: Enanta Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Enanta Pharmaceuticals (United States) work in?

In all years, 50% of research at Enanta Pharmaceuticals (United States) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (48%), Biochemistry, Genetics and Molecular Biology (21%), Chemistry (14%). It does 1.9× the world's share of Health Sciences.

Health Sciences: 27 fractional works · 49.7% of its workMedicine: 27 fractional works · 48.3% of its workEpidemiology: 12 fractional works · 21.0% of its workInfectious Diseases: 3 fractional works · 4.9% of its workHepatology: 2 fractional works · 3.9% of its workPulmonary and Respiratory Medicine: 2 fractional works · 3.2% of its workPharmacology: 2 fractional works · 2.7% of its workOncology: 1 fractional works · 2.6% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.8% of its workPhysiology: 1 fractional works · 1.8% of its workRheumatology: 1 fractional works · 1.4% of its workImmunology and Allergy: 0 fractional works · 0.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.9% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.9% of its workPsychiatry and Mental health: 0 fractional works · 0.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.3% of its workNephrology: 0 fractional works · 0.2% of its workPathology and Forensic Medicine: 0 fractional works · 0.2% of its workSurgery: 0 fractional works · 0.2% of its workHealth Professions: 1 fractional works · 1.2% of its workGeneral Health Professions: 0 fractional works · 0.9% of its workPharmacy: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.2% of its workSmall Animals: 0 fractional works · 0.2% of its workLife Sciences: 17 fractional works · 31.7% of its workBiochemistry, Genetics and Molecular Biology: 12 fractional works · 21.4% of its workMolecular Biology: 9 fractional works · 15.7% of its workGenetics: 2 fractional works · 3.8% of its workMolecular Medicine: 1 fractional works · 1.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 4 fractional works · 7.0% of its workImmunology: 4 fractional works · 6.8% of its workMicrobiology: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 2.2% of its workAnimal Science and Zoology: 0 fractional works · 0.8% of its workPlant Science: 0 fractional works · 0.6% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.4% of its workInsect Science: 0 fractional works · 0.4% of its workNeuroscience: 0 fractional works · 0.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.6% of its workPhysical Sciences: 9 fractional works · 15.6% of its workChemistry: 8 fractional works · 14.0% of its workOrganic Chemistry: 7 fractional works · 11.9% of its workSpectroscopy: 1 fractional works · 1.6% of its workInorganic Chemistry: 0 fractional works · 0.6% of its workComputer Science: 1 fractional works · 1.1% of its workComputational Theory and Mathematics: 1 fractional works · 0.9% of its workArtificial Intelligence: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.3% of its workEngineering: 0 fractional works · 0.2% of its workSocial Sciences: 2 fractional works · 3.0% of its workSocial Sciences: 2 fractional works · 2.9% of its workUrban Studies: 1 fractional works · 2.3% of its workSociology and Political Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workArts and Humanities: 0 fractional works · 0.1% of its workALL ITS WORKEnantaPharmaceuticals…55fractional works, all years
Life Sciences32%Physical Sciences16%Health Sciences50%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Medicine2748.3%
    2. Health Professions11.2%
    3. Veterinary00.2%
    1. Biochemistry, Genetics and Molecular Biology1221.4%
    2. Immunology and Microbiology47.0%
    3. Agricultural and Biological Sciences12.2%
    4. Neuroscience00.6%
    5. Pharmacology, Toxicology and Pharmaceutics00.6%
    1. Chemistry814.0%
    2. Computer Science11.1%
    3. Materials Science00.3%
    4. Engineering00.2%
    1. Social Sciences22.9%
    2. Arts and Humanities00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Enanta Pharmaceuticals (United States)?

Ranked on the quality score, Yat Sun Or, Alaa Mohammad Ahmad and Michael H. J. Rhodin lead among researchers whose main affiliation is Enanta Pharmaceuticals (United States).

  1. 1 Yat Sun Or United States · #1,417,667 worldwide 1.7k citations · 71 works
  2. 2 Alaa Mohammad Ahmad United States · #1,632,796 worldwide 1.1k citations · 62 works
  3. 3 Michael H. J. Rhodin United States · #2,247,775 worldwide 208 citations · 21 works
  4. 4 Ly Phan United States · #2,794,720 worldwide 494 citations · 25 works
  5. 5 Mary Chau United States · #4,212,453 worldwide 17 citations · 17 works
  6. 6 Yonghua Gai United States · #4,471,983 worldwide 277 citations · 24 works
All ranked researchers at Enanta Pharmaceuticals (United States)

What are the most cited papers from Enanta Pharmaceuticals (United States)?

The most cited paper from Enanta Pharmaceuticals (United States) is "Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry–Based Assays" (Andrew N. Hoofnagle et al., 2015), with 238 citations. Next come "Papillomavirus E2 induces senescence in HPV‐positive cells via pRB‐ and p21CIP‐dependent pathways" (210) and "EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study" (118).

Most cited papers
#PaperReleasedCitations
1 Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry–Based Assays Andrew N. Hoofnagle et al. · Clinical Chemistry Open access 30 Dec 2015 238
2 Papillomavirus E2 induces senescence in HPV‐positive cells via pRB‐ and p21CIP‐dependent pathways Susanne I. Wells, Delicia A. Francis, Alla Y. Karpova et al. · The EMBO Journal Open access Nov 2000 210
3 EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study Vlad Ratziu, Mary Eugenia Rinella, Brent A. Neuschwander‐Tetri et al. · Journal of Hepatology Open access 2 Nov 2021 118
4 In Vitro and In Vivo Antiviral Activity and Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor ABT-450 Tami Pilot-Matias, Rakesh L. Tripathi, Daniel E. Cohen et al. · Antimicrobial Agents and Chemotherapy Open access 2 Dec 2014 117
5 Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling Shaoguang Li, Anthony D. Couvillon, Bradley B. Brasher et al. · The EMBO Journal Open access 3 Dec 2001 106
All 86 most cited papers, with filters and sorting

Which keywords describe research at Enanta Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Vaccine Development, Human Metapneumovirus, Respiratory Syncytial Virus, Treatment, Antimicrobial Resistance, Immune Response and Clinical Practice Guidelines.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology16▲ 7.1×18 topics
  2. Vaccine Development5▲ 29×3 topics
  3. Human Metapneumovirus4▲ 163×1 topic
  4. Respiratory Syncytial Virus4▲ 163×1 topic
  5. Treatment4▲ 5.7×5 topics
  6. Inflammation4▲ 2.9×10 topics
  7. Antimicrobial Resistance3▲ 25×2 topics
  8. Immune Response3▲ 9.6×7 topics
  9. Clinical Practice Guidelines3▲ 10×2 topics
  10. Pathogenesis3▲ 10×8 topics
  11. Community-Acquired Pneumonia3▲ 125×1 topic
  12. Pneumococcal Conjugate Vaccine3▲ 125×1 topic
  13. Diagnosis3▲ 4.5×5 topics
  14. Cancer2▲ 3.2×11 topics
  15. Antiviral Therapy2▲ 29×3 topics
  16. Synthesis2▲ 7.5×7 topics
  17. Enantioselective Synthesis2▲ 24×3 topics
  18. Genomics2▲ 11×3 topics
  19. Liver Disease2▲ 29×2 topics
  20. Antiretroviral Therapy2▲ 15×2 topics
  21. Drug Discovery2▲ 8.8×3 topics
  22. Pandemic2▲ 7.6×3 topics
  23. Genetic Variation2▲ 10×2 topics
  24. Medicinal Chemistry2▲ 8.7×4 topics
  25. Vaccine2▲ 7.7×7 topics
  26. Hepatocellular Carcinoma2▲ 13×2 topics
  27. Immunosuppressive Therapy2▲ 15×2 topics
  28. Transcriptional Regulation2▲ 12×2 topics
  29. Hepatitis C Virus2▲ 51×1 topic
  30. Ribavirin2▲ 51×1 topic
  31. Antibiotic Resistance1▲ 6.4×4 topics
  32. Anticancer Agents1▲ 10×3 topics
  33. Nuclear Receptors1▲ 14×2 topics
  34. Olefin Metathesis1▲ 44×1 topic
  35. Ruthenium Catalysts1▲ 44×1 topic
  36. Foldamers1▲ 29×1 topic
  37. Influenza1▲ 51×1 topic
  38. Peptide Synthesis1▲ 29×1 topic
  39. Virus1▲ 20×1 topic
  40. Biological Evaluation1▲ 18×3 topics

Which research topics does Enanta Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Respiratory viral infections research, Asthma and respiratory diseases, Influenza Virus Research Studies and Viral Infections and Immunology Research.

Respiratory viral infect…3Respiratory viral infections research: 3 fractional worksAsthma and respiratory d…1Asthma and respiratory diseases: 1 fractional worksInfluenza Virus Research…1Influenza Virus Research Studies: 1 fractional worksViral Infections and Immunology Research: 1 fractional worksMast cells and histamine: 1 fractional worksPneumonia and Respirator…1Pneumonia and Respiratory Infections: 1 fractional worksVirus-based gene therapy research: 0 fractional worksDrug Transport and Resistance Mechanisms: 0 fractional worksLiver Disease Diagnosis and Treatment: 0 fractional worksInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 0 fractional works
EpidemiologyPhysiologyCardiology and Cardiovascular MedicineImmunology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Respiratory viral infections research Epidemiology 3 works
  2. 2 Asthma and respiratory diseases Physiology 1 works
  3. 3 Influenza Virus Research Studies Epidemiology 1 works
  4. 4 Viral Infections and Immunology Research Cardiology and Cardiovascular Medicine 1 works
  5. 5 Mast cells and histamine Immunology 1 works
  6. 6 Pneumonia and Respiratory Infections Epidemiology 1 works
  7. 7 Virus-based gene therapy research Genetics 0 works
  8. 8 Drug Transport and Resistance Mechanisms Oncology 0 works
  9. 9 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  10. 10 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.8%not open55.2%

World: 40% of research is openly available.

with international co-authors17.7%domestic only82.3%

World: 18% is written across borders.

How has Enanta Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 15% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Enanta Pharmaceuticals (United States) as a percentage of every work published that year, 0.000031% in 2024.

still counting0.00010%0.00020%0.00030%Enanta Pharmaceuticals (United States)0.000017% in 202520102020

Fractional works of Enanta Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Watertown

All research institutions in Watertown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Enanta Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.